Adastra Holdings Ltd. (C:XTRX)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Apr 15, 2024 05:00 pm ET

Adastra Holdings Announces Lachlan McLeod as Interim CEO

LANGLEY, BC / ACCESSWIRE / April 15, 2024/ Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to announce the appointment of Lachlan McLeod, CPA, as Interim Chief Executive Officer, effective April 12, 2024. Mr. McLeod is currently the Company's CFO and Corporate Secretary and will continue to hold those roles.

Apr 02, 2024 05:00 pm ET

Adastra Holdings Announces New Director

LANGLEY, BC / ACCESSWIRE / April 2, 2024 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to announce the appointment of Jon Edwards to its Board of Directors, effective April 2, 2024.

Mar 14, 2024 05:00 pm ET

Adastra Holdings Announces Record Total Purchase Orders Received in January and February

LANGLEY, BC / ACCESSWIRE / March 14, 2024 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to announce a record in total purchase orders ("POs") received in January and February 2024 of approximately CAD $8.3M.

Mar 01, 2024 05:00 pm ET

Adastra Holdings Announces Record Single Purchase Order For Over $1M

LANGLEY, BC / ACCESSWIRE / March 1, 2024 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2E) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to announce that it has received a Purchase Order ("PO") for CAD $1,047,439 from the Alberta Gaming, Liquor & Cannabis ("AGLC").

Dec 15, 2023 05:30 pm ET

Adastra Holdings Announces Change of Auditor

LANGLEY, BC / ACCESSWIRE / December 15, 2023 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of the two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, announces that it has changed its auditor from Davidson & Company LLP (the "Former Auditor") to MNP LLP (the "Successor Auditor"). The Company decided to change its auditor

Nov 29, 2023 04:30 pm ET

Adastra Holdings Reports Third Quarter Results; Demonstrating Gross Revenues of $8.1m

LANGLEY, BC / ACCESSWIRE / November 29, 2023/ Adastra Holdings Ltd. (CSE:XTRX) (FRA:D2EP) (" Adastra " or the " Company "), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to report financial results for the three and nine months ended September 30, 2023. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

Oct 11, 2023 08:30 am ET

Adastra Holdings Provides Corporate Update Following 2023 Growup Awards Victory as Brand of The Year

LANGLEY, BC / ACCESSWIRE / October 11, 2023 / Adastra Holdings Ltd. (CSE:XTRX) (FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to provide the following corporate update, highlighting the achievements accomplished thus far in 2023 and outlining the various initiatives planned for the remainder of the year.

Aug 24, 2023 05:15 pm ET

Adastra Holdings Receives Dual Nominations at 2023 Growup Awards and Gala

Growup Recognizes Excellence in Cannabis Brands and Industry Contributions

Aug 17, 2023 08:45 am ET

Adastra Holdings Reports Second Quarter Results; Demonstrating Record Quarterly Revenue of $10.9m

Record Q2 2023 revenue of $10.9M, an increase of 205% from Q2 2022

May 30, 2023 08:10 pm ET

Adastra Holdings Reports First Quarter Results; Demonstrating Record Quarterly Gross Revenues of $9.5M

LANGLEY, BC / ACCESSWIRE / May 30, 2023 / Adastra Holdings Ltd. (CSE:XTRX) (FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to report financial results for the three months ended March 31, 2023.

May 02, 2023 07:40 am ET

Adastra Holdings Reports FY2022 Results; Demonstrating A Second Year of Record Revenue

LANGLEY, BC / ACCESSWIRE / May 2, 2023 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to report financial results for the fourth quarter and the year ended December 31, 2022.

Mar 16, 2023 07:30 am ET

Adastra Accelerates Growth; 152% Increase in Shipment Volume

LANGLEY, BC / ACCESSWIRE / March 16, 2023 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis company focused on processing, adult-use and medical sales, organoleptic testing and analytical testing, announces record shipment volume for January and February 2023 and plans to further accelerate product and brand presence across Canada.

Mar 15, 2023 04:35 pm ET

Adastra to Defend Lawsuit

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Mar 03, 2023 03:25 pm ET

Adastra Labs Clarifies and Retracts Certain Disclosure Related to its Receipt of Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Licence

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Feb 22, 2023 04:15 pm ET

Adastra Labs Receives Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Dealer’s License

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Feb 14, 2023 07:30 am ET

Leadership Update: Adastra Appoints Lachlan McLeod as CFO

LANGLEY, BC / ACCESSWIRE / February 14, 2023 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis company and producer of two top Canadian concentrate brands, with a focus on processing, adult-use and medical sales, organoleptic and analytical testing, today announced that Lachlan McLeod, CPA of Fehr & Associates, has been appointed Chief Financial Officer.

Feb 09, 2023 07:30 am ET

Adastra Completes Transaction to Terminate Legacy Supply Agreement, Bringing Phyto Extractions Brand 100% In-House

LANGLEY, BC / ACCESSWIRE / February 9, 2023 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company") a leading cannabis company and producer of two top Canadian concentrate brands, with a focus on processing, adult-use and medical sales, organoleptic and analytical testing, announces the termination of a legacy supply agreement for the Company's Phyto Extractions Brand ("Phyto").

Dec 01, 2022 04:25 pm ET

Adastra Holdings Reports Third Quarter Results; Demonstrating Third Consecutive Quarter of Record Revenue

LANGLEY, BC / ACCESSWIRE / December 1, 2022 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis company and producer of two top Canadian concentrates brands, with a focus on processing, adult-use and medical sales, organoleptic testing and analytical testing, is pleased to report financial results for the three and nine months ended September 30, 2022.

Aug 31, 2022 07:30 am ET

Adastra Receives Controlled Substances Dealer's License

LANGLEY, BC / ACCESSWIRE / August 31, 2022 / Adastra Holdings Ltd. (CSE:XTRX) (FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis company focused on processing, adult-use and medical sales, organoleptic testing and analytical testing, is pleased to announce that the Company has received its Controlled Drug and Substances Dealer's License ("Dealer's License") on August 24, 2022. This license allows Adastra to process psilocybin and psilocin, the active compounds derived from psychedelic mushrooms.

Aug 26, 2022 05:00 pm ET

Adastra Holdings Reports Record Second Quarter Results; Momentum Accelerating in Second Half of the Year

LANGLEY, BC / ACCESSWIRE / August 26, 2022 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis company focused on processing, adult-use and medical sales, organoleptic testing and analytical testing, is pleased to report financial results for the three and six months ended June 30, 2022.

Jun 29, 2022 07:45 am ET

Adastra Holdings Continues to Execute on Transformational Strategy; New Product Launches; Outlines Growth Strategy

Endgame Extracts brand launched in BC in Q1 2022 with a 100% case sell-through achieved in 48-hours; Endgame is currently ranked #3 and #4 for its shatter sales in BC – with launches planned for other large Canadian markets (Alberta and Ontario) to follow Adastra continues to add new revenue streams, including the addition of new co-manufacturing contracts for several well-known Canadian brands to start in 2022Continued expansion for product sales and distribution across Canada – Phyto Extractions is now available in the Northwest Territories and YukonExpanded capabilities and automation: pr

May 30, 2022 07:45 am ET

Adastra Holdings Reports First Quarter Results

Generated record gross revenues of $2,286,721 in Q1 2022, representing 288% growth compared to Q1 2021Maintained a strong capital position in Q1 2022 with $28,176,801 in assets, and $6,712,176 in liabilities LANGLEY, BC, May 30, 2022 /CNW/ - Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") is pleased to announce that it has filed its consolidated financial statements and related management discussion and analysis for the three months ended March 31, 2022, both of which are available at www.sedar.com.

May 16, 2022 07:30 am ET

Adastra Holdings Announces New Director

LANGLEY, BC, May 16, 2022 /CNW/ - Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company"), a Health Canada Licensed cannabis company focused on processing, sales, organoleptic testing, and analytical testing, is pleased to announce the appointment of Smoke Wallin to the Company's board of directors.

May 04, 2022 07:45 am ET

Adastra Holdings Announces 2021 Annual Financial Results and Corporate Update

Generated record gross revenues of $5.6 million in 2021, representing 124% growth YOYMaintained a strong capital position with $28.8 million of assets, and $6.4 million of liabilitiesLANGLEY, BC, May 4, 2022 /CNW/ - Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") is pleased to announce that it has filed its consolidated financial statements and related management discussion and analysis for the year ended December 31, 2021, both of which are available at www.sedar.com.

Apr 11, 2022 07:30 am ET

Adastra Announces Submission of Medical Sales License Application and Engagement of IR Labs Inc. to Provide Investor Relations Services

LANGLEY, BC, April 11, 2022 /CNW/ - Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company"), a Health Canada Licensed cannabis company focused on processing, sales, organoleptic testing, and analytical testing, is pleased to announce the submission of its Medical Sales License application to Health Canada on April 1, 2022.

Apr 07, 2022 07:30 am ET

Adastra Announces Successful Soft Launch of Endgame Brand in BC

LANGLEY, BC, April 7, 2022 /CNW/ - Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company"), a Health Canada Licensed cannabis company focused on processing, sales, organoleptic and analytical testing, is excited to announce that its newly developed brand, Endgame, which was soft-launched last week, sold out in less than 24 hours of delivery to the British Columbia Liquor Distribution Branch ("BCLDB"). Endgame's initial SKU delivery included two varieties of vaporizer cartridges: Mosa x Blood Orange and White Rhino x Raspberry Lemon.

Mar 29, 2022 07:30 am ET

Adastra Announces a Record Production Month and Management Changes

LANGLEY, BC, March 29, 2022 /CNW/ - Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company"), a Health Canada Licensed cannabis company focused on processing, sales, organoleptic and analytical testing, is pleased to report that its wholly owned subsidiary Adastra Labs Inc. achieved a record month of production volume in February, more than doubling outputs.

Mar 25, 2022 07:30 am ET

Adastra Announces Completed Submission of Controlled Substances Dealer's License Application

LANGLEY, BC, March 25, 2022 /CNW/ - Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") a Health Canada Licensed cannabis company focused on processing, sales, organoleptic testing and analytical testing, is pleased to announce it completed the submission of its application for a Controlled Drugs and Substances Dealer's License ("Dealer's License") on March 23, 2022.

Mar 15, 2022 03:15 pm ET

The Power Play by The Market Herald Releases New Interviews With Silver Bullet Mines, Northstar Gold, and Adastra Holdings

VANCOUVER, BC / ACCESSWIRE/ March 15, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Silver Bullet Mines, Northstar Gold, and Adastra Holdings on their latest news.

Mar 15, 2022 07:30 am ET

Adastra Holdings Announces Co-Manufacturing Partnership to bring Zyre Brands to Market

LANGLEY, BC, March 15, 2022 /CNW/ - Adastra Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) ("Adastra" or the "Company") a Health Canada Licensed cannabis processing, sales, organoleptic testing, and analytical testing services company, is pleased to announce a private label manufacturing agreement with Zyre Brands Corp. ("Zyre").

Feb 23, 2022 01:45 pm ET

The Power Play by The Market Herald Releases New Interviews With Algernon Pharmaceuticals, Adastra Holdings and C3 Metals

VANCOUVER, BC / ACCESSWIRE/ February 23, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Algernon Pharmaceuticals, Adastra Holdings and C3 Metals on their latest news.

Feb 23, 2022 06:30 am ET

Adastra Holdings Expands Co-Manufacturing Portfolio and Provides Facility Expansion Update

LANGLEY, BC, Feb. 23, 2022 /CNW/ - Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") has started the new year strong by signing co-manufacturing agreements to produce high-potency, pure hydrocarbon- extracted concentrate products, continuing to expand its portfolio of brand partners, and growing the Company's dossier of SKUs in the Canadian market.

Dec 20, 2021 06:30 am ET

Adastra Holdings Receives Flower Sales License from Health Canada

Dec 02, 2021 04:55 pm ET

The Power Play by the Market Herald Releases New Interviews With Lumiera, Fsd Pharma, HydroGraph, and Adastra Holdings

VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / The Power Play by The Market Herald has announced the release of new interviews with Lumiera, FSD Pharma, HydroGraph, and Adastra Holdings discussing their latest press releases.

Dec 02, 2021 08:00 am ET

Adastra Holdings Reports Record Third Quarter Results

LANGLEY, BC, Dec. 2, 2021 /CNW/ - Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") has today filed its consolidated financial statements and related management discussion and analysis for the three and nine months ended September 30, 2021, and 2020, both of which are available at www.sedar.com.

Oct 15, 2021 09:08 am ET

Adastra Holdings Provides Product Growth Update and Announces Insider Open-Market Stock Purchases

LANGLEY, BC, Oct. 15, 2021 /PRNewswire/ - Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") today announced positive operational and financial developments as the Company continues to pursue its mission to be a leader in the development and manufacture of pharma-quality, cannabis API and derivative products. These developments include record shipments in September, product portfolio expansion, and continued progress with Health Canada regarding its Controlled Substances Dealers License application.

Oct 15, 2021 09:08 am ET

Adastra Holdings Provides Product Growth Update and Announces Insider Open-Market Stock Purchases

LANGLEY, BC, Oct. 15, 2021 /CNW/ - Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") today announced positive operational and financial developments as the Company continues to pursue its mission to be a leader in the development and manufacture of pharma-quality, cannabis API and derivative products. These developments include record shipments in September, product portfolio expansion, and continued progress with Health Canada regarding its Controlled Substances Dealers License application.

Oct 08, 2021 09:34 am ET

Adastra Announces Supply & Purchase Agreement with Sitka Weed Works

Adds High-Quality Craft Flowers, Including Unique Genetics Previously Unavailable in Canada, to Adastra Portfolio

Sep 30, 2021 08:30 am ET

Adastra Holdings Announces Expansion of Phyto Extractions Product Line Distribution into Yukon Territory

Initial Phyto Extractions Products Now Listed in Yukon Territory Sold Out, Awaiting Second Fulfillment

Sep 29, 2021 08:30 am ET

Adastra Holdings Enters Market with Creation of THC-Free 99% Pure CBD Isolate

Sep 29, 2021 08:30 am ET

Adastra Holdings Enters Market with Creation of THC-Free 99% Pure CBD Isolate

Sep 20, 2021 09:15 am ET

Adastra Holdings Completes Acquisition of Phyto Extractions

Provides additional detail on the strategy to leverage the Phyto brand to drive accelerated growthThe Company expects $5 million in monthly sales by July 2022

Sep 16, 2021 07:55 am ET

Adastra Enters into Share Purchase Agreement for Acquisition of Phyto Extractions

Sep 15, 2021 07:50 am ET

Adastra Holdings Announces Record Sales in August

Sales of nearly $1.7M in August 2021 set a new monthly record, exceeding the previous monthly record of $1.5M in May 2021

Sep 09, 2021 04:15 pm ET

Adastra Holdings Announces Product Listings From Ontario Cannabis Store

Santa Cruz Haze Shatter Vape Cartridge, to be stocked at OCS this November

Sep 08, 2021 08:30 am ET

Adastra Holdings CEO Provides Corporate Update

Sep 03, 2021 08:45 am ET

Adastra Launches Phyto Extractions Full Spectrum Shatter Vape Cartridge Line

Hydrocarbon extracted shatter containing cannabis terpenes with 79-82% THC potency; First-of-its-kind product, targeting first-time consumers of cannabis products

Sep 01, 2021 08:15 am ET

Adastra's Application for Controlled Substances Dealer's License Under Review by Health Canada

Aug 31, 2021 10:33 pm ET

Phyto Extractions Inc. Completes Acquisition of PerceiveMD, a Multidisciplinary Centre for Medical Cannabis and Psychedelic Therapies

LANGLEY, BC, Aug. 31, 2021 /CNW/ - Phyto Extractions Inc. (formerly Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) ("Phyto" or the "Company") is pleased to announce, further to its news release dated August 11, 2021 that it has acquired, indirectly through its wholly-owned subsidiary Adastra Labs Inc. ("Adastra") all of the issued and outstanding shares in the capital of 1225140 B.C. Ltd., doing business as PerceiveMD ("PerceiveMD") from the shareholders (the "Vendors") of PerceiveMD, pursuant to the terms of a share purchase agreement dated August 10, 2021 (the "Share Purchase Agreemen

Aug 31, 2021 02:37 pm ET

CSE Bulletin: Name Change - Phyto Extractions Inc. (XTRX)

Toronto, Ontario--(Newsfile Corp. - Le 31 août/August 2021) Phyto Extractions Inc. has announced a name change to Adastra Holdings Ltd.

Aug 27, 2021 08:15 am ET

Phyto Extractions Announces Name Change to Adastra Holdings Ltd.

LANGLEY, BC, Aug. 27, 2021 /CNW/ - Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) ("Phyto" or the "Company") is pleased to announce a name change from "Phyto Extractions Inc." to "Adastra Holdings Ltd." (the "Name Change"), to be effective on September 1, 2021. Trading of the Company's common shares is expected to resume under the new name and under the same ticker symbol "XTRX" on the Canadian Securities Exchange as of market open on September 1, 2021. In connection with the Name Change, the Company's new CUSIP will be 00654D100 and the new ISIN will b

Aug 24, 2021 05:30 pm ET

Phyto Extractions Inc. Provides Update on Proposed Acquisition

LANGLEY, BC, Aug. 24, 2021 /CNW/ - Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the "Company") is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.

Aug 19, 2021 08:15 am ET

Phyto Extractions Submits Application for Dried Cannabis Flower Sales Licence

LANGLEY, BC, Aug. 19, 2021 /CNW/ - Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (Frankfurt: D2EP) ("Phyto Extractions™", "Phyto" or the "Company") is a holder of a federal licence to process and sell cannabis extract products, edibles, and topicals under the Cannabis Act. The Company is pleased to announce that it has submitted a licence amendment to Health Canada that, if approved, will enable Phyto to sell dried cannabis flower to provincially authorized distributors and retailers and registered medical patients.

Aug 18, 2021 04:15 pm ET

Phyto Extractions' Shatter Run Visits 420th Retailer on Final Leg of Cross-Country Sales Tour

LANGLEY, BC / ACCESSWIRE / August 18, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(FSE:D2EP) ("Phyto Extractions™", "Phyto" or the "Company") strives to continuously bring consumers new and innovative products to enhance their experience and overall enjoyment. Phyto Extractions™ 'is known for its iconic concentrate products and brand success, built during the legacy market era. Shatter is Phyto's newest product line to launch in the Canadian medical and adult-use markets and hit shelves this summer in

Aug 11, 2021 04:15 pm ET

Phyto Extractions Inc. Announces Proposed Acquisition of PerceiveMD, a Multidisciplinary Centre for Medical Cannabis and Psychedelic Therapies

LANGLEY, BC / ACCESSWIRE / August 11, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(FRA:D2EP) (“Phyto Extractions™” or the “Company”) is pleased to announce that it has entered into a share purchase agreement dated August 10, 2021 (the “Share Purchase Agreement”) pursuant to which the Company has agreed to acquire, indirectly through its wholly-owned subsidiary Adastra La

Jul 15, 2021 09:00 am ET

Phyto Extractions Secures Biomass Supply Agreement

LANGLEY, BC / ACCESSWIRE / July 15, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(Frankfurt:D2EP) ("Phyto Extractions™, "Phyto" or the "Company") has secured a supply agreement for dried cannabis with a major Canadian License Holder. The supply agreement will provide upwards of 12,000 kgs of dried cannabis biomass over six months.

Jul 08, 2021 07:00 am ET

Phyto Extractions' RV Visits Retailers in Cross-Country Tour

LANGLEY, BC / ACCESSWIRE / July 8, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(Frankfurt:D2EP) ("Phyto Extractions™, "Phyto" or the "Company") strives to continuously bring consumers new and innovative products to enhance their experience and overall enjoyment. Phyto Extractions™' is known for its iconic concentrate product - Shatter and brand success as it was built during the legacy or "grey" market era. Shatter is Phyto's newest product line to launch in the Canadian medical

Jun 02, 2021 07:30 am ET

Phyto Extractions Inc. Officially Launches Shatter For Adult-Use Market

LANGLEY, BC / ACCESSWIRE / June 2, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(FRA:D2EP) ("Phyto Extractions™or the "Company") strives to continuously bring consumers new and innovative products to enhance their experience and overall enjoyment. Shatter is Phyto Extractions™ newest product category, with three new high THC extract offerings produced from single-source strains (local to BC and ON). Available in three highly popular strains including: Blue Gorilla OG, Pink Kush and D Bubba, all Phyto Extractions͐

May 25, 2021 07:30 am ET

Phyto Extractions Shatter Now Available Nationally for Medical Consumers

LANGLEY, BC / ACCESSWIRE / May 25, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX) (Frankfurt:D2EP) ("Phyto Extractions™"or the "Company) is excited to announce its shatter product launch which is now available nationally for its medical consumers at CannMart.com, with planned distribution to recreational consumers via anticipated future sales to provincial monopoly wholesalers.

May 10, 2021 04:00 am ET

Phyto Extractions Announces Michael Forbes as New CEO

LANGLEY, BC / ACCESSWIRE / May 10, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(Frankfurt:D2EP) ("Phyto Extractions" or the "Company") is proud to announce Michael Forbes Pharm, MBA as its new CEO and director.

Apr 30, 2021 08:30 pm ET

Phyto Extractions Announces Interim CEO and Director Transition

LANGLEY, BC / ACCESSWIRE / April 30, 2021 / Phyto Extractions Inc. (formerly Adastra Labs Holdings Ltd.) (CSE:XTRX) (FRA:D2EP) ("Phyto Extractions" or the "Company") announces that interim CEO J. Scott Munro has transitioned from his roles as Interim CEO and director of the Company to new external ventures. With his experience in C-suite positions in various private and public companies and wealth of management knowledge, Munro served as a seasoned driver whose role as Interim CEO and director steadily steered Phyto Extractions on i

Apr 28, 2021 08:00 am ET

Cannabis 2.0 Is Really Here - New Distribution and R&D Bolster Extract Capabilities

Point Roberts, Washington and Delta, British Columbia--(Newsfile Corp. - April 28, 2021) - Investorideas.com, a leading investor news resource covering cannabis and hemp stocks releases a special report on the accelerated growth within the extracts and "Cannabis 2.0" categories as more companies further distribution and expand R&D capabilities, featuring Phyto Extractions Inc. (formerly Adastra Labs Holdings Ltd.) (CSE: XTRX).

Apr 26, 2021 11:50 am ET

Phyto Extractions(TM) Engages Independent Trading Group Inc. for Market-Making

LANGLEY, BC / ACCESSWIRE / April 26, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (Frankfurt: D2EP) ("Phyto Extractions™" or the "Company) is pleased to announce that it subject to regulatory approval, has retained Independent Trading Group (ITG) to provide market-making services in compliance with the policies and guidelines of the Canadian Securities Exchange (CSE) and other applicable legislation

Apr 23, 2021 01:55 pm ET

Phyto Extractions(TM) Announces Proposed Warrant Amendment

LANGLEY, BC / ACCESSWIRE / April 23, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(Frankfurt:D2EP) ("Phyto Extractions™" or the "Company") announces that, subject to approval from the Canadian Securities Exchange, it intends to amend the terms of all 1,964,151 warrants (each, a "Warrant") that were issued by the Company in connection with its non-brokered private placement which closed on December 19, 2019 to make the Warrants transferable subject to compliance with applicable securities laws. Currently, the Wa

Apr 22, 2021 12:35 pm ET

Phyto Extractions(TM) Announces Health Canada R&D License Addendum

LANGLEY, BC / ACCESSWIRE / April 22, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX) (Frankfurt:D2EP) ("Phyto Extractions™" or the "Company) is pleased to announce that it has received its R&D license addendum in Adastra Labs Inc. that will permit some limited human testing by licensed researchers administering or distributing cannabis to human research subjects using cannabis obtained from a holder of a license for processing in the final form of cannabis.

Apr 21, 2021 11:30 am ET

Phyto Extractions(TM) - Hydrocarbon Extraction Now Producing Shatter for Canadian Market

LANGLEY, BC / ACCESSWIRE / April 21, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX) (Frankfurt:D2EP) ("Phyto Extractions™" or the "Company) is pleased to announce that it is now producing cannabis shatter products for the Canadian market after wholly-owned subsidiary Adastra Labs Inc.'s commissioning of new hydrocarbon extraction equipment ahead of schedule.

Apr 09, 2021 12:05 pm ET

Phyto Extractions(TM) (Adastra Labs) Launches New Shatter Product Line to Canadian Retail Market in Time for 420

LANGLEY, BC / Accesswire / April 9, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(Frankfurt:D2EP) ("Phyto Extractions™" or the "Company") is proud to announce the launch of three new Shatter Products, adding to its product line in the burgeoning cannabis extracts market.

Mar 29, 2021 02:19 pm ET

IIROC Trade Resumption - XTRX

VANCOUVER, BC, March 29, 2021 /CNW/ - Trading resumes in:

Mar 11, 2021 07:43 am ET

IIROC Trading Halt - XTRX

VANCOUVER, BC, March 11, 2021 /CNW/ - The following issues have been halted by IIROC:

Dec 23, 2020 07:00 am ET

Adastra Expands to Provide BHO while Inking Terms with Phyto Extractions as the Brands Quarter on Quarter Revenue Doubles in Q3 2020

LANGLEY, BC / ACCESSWIRE / December 23, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the signing of a term sheet for the acquisition of Phyto Extractions Brands ("Phyto Extractions") and permitting of its hydrocarbon extraction expansion.

Dec 18, 2020 07:00 am ET

Adastra Signs Joint Venture Agreement with JOYN Botanicals to Solidify Cannabis 3.0 Edible and Beverage Technology Partnership

According to Arcview Group's research "The cannabis 2.0 market could be worth more than $4.1 billion in Canada and the US by 2022." Further, according to Statista.com, the Canadian THC infused products market is forecasted to be increased to approximately 579.2 million US dollars by 2025.

Dec 14, 2020 07:00 am ET

Adastra Near-Doubles Quarter on Quarter Revenue and Reports Financial Results for the Q3 2020

LANGLEY, BC / ACCESSWIRE / December 14, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce its financial and operating results for the third quarter financial results for the period ended September 30, 2020.

Dec 07, 2020 08:00 am ET

Adastra Announces Processing Agreement with Solargram to Reflect the Company's Multi-tiered Approach to Increase Sales Revenue

LANGLEY, BC / ACCESSWIRE / December 7, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce a processing agreement with Solargram Farms Corp. ("Solargram"), a company whose entire shares are to be vended into Captiva Verde Land Corp. ("Captiva Verde") (PWR) subject to Health Canada approval.

Nov 13, 2020 03:12 pm ET

Adastra Commences Full-Scale Cryo-Ethanol Extraction Operations

LANGLEY, BC / ACCESSWIRE / November 13, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the full-scale operation of its cryo-ethanol extraction system from Evolved Extraction Solutions ("Evolved").

Oct 07, 2020 04:00 pm ET

Adastra Progresses Toward Iconic Phyto Extractions Brands Acquisition

LANGLEY, BC / ACCESSWIRE / October 7, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX) (FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce completion of initial due diligence for the acquisition of Phyto Extractions Brands ("Phyto Extractions").

Oct 02, 2020 04:45 pm ET

Adastra Commissions Industrial Scale Cryo-Ethanol System to Triple Capacity

LANGLEY, BC / ACCESSWIRE / October 2, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT: D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the completion of installation and start of commissioning of its cryo-ethanol extraction system from Evolved Extraction Solutions ("Evolved").

Sep 18, 2020 04:00 pm ET

Adastra Signs LOI to Acquire Iconic Legacy Market Phyto Extractions Brands

LANGLEY, BC / ACCESSWIRE / September 18, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce it has signed a Letter of Intent ("LOI") for the acquisition of Phyto Extractions Brands ("Phyto Extractions").

Sep 16, 2020 03:00 am ET

Adastra Begins Cannabis Hydrocarbon Extraction Expansion Plan

LANGLEY, BC / ACCESSWIRE / September 16, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the commencement of its hydrocarbon extraction expansion plan.

Aug 25, 2020 04:00 pm ET

Adastra to Partner with JOYN for Disruptive Cannabis Powder Tech

LANGLEY, BC / ACCESSWIRE / August 25, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce a Letter of Intent (LOI) to enter into a partnership with JOYN Botanicals Ltd. ("JOYN") for the exclusive Canadian use of its patent-pending SoluCann cannabis powder for edibles, concentrates and beverages.

Aug 20, 2020 04:00 pm ET

Adastra to Exclusively Produce Cessa CBD Concentrate Products

LANGLEY, BC / ACCESSWIRE / August 20, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX) (FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce it has been engaged by a cannabis brands company for the exclusive production of a new line of products branded under the label Cessa CBD ("Cessa").

Aug 17, 2020 08:10 pm ET

Adastra Announces Supply Agreement with Pure Sunfarms

LANGLEY, BC / ACCESSWIRE / August 17, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce a cannabis supply agreement with Pure Sunfarms Corp. ("Pure Sunfarms").

Aug 14, 2020 04:00 pm ET

Adastra Triples Capacity with Purchase of Industrial Scale Cryo-Ethanol System

LANGLEY, BC / ACCESSWIRE / August 14, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the purchase of a cryo-ethanol extraction system from Evolved Extraction Solutions ("Evolved").

Aug 12, 2020 04:00 pm ET

Adastra Announces Fulfillment of Distillate & Vape Cart Purchase Orders

LANGLEY, BC / ACCESSWIRE / August 12, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the fulfillment of its purchase order for bulk distillate and an order for 30,000 vaporizing cartridges from CannMart Inc. ("CannMart") a majority owned subsidiary of Namaste Technologies Inc. ("Namaste") (N) (M5BQ) (NXTTF).

Aug 11, 2020 06:10 pm ET

Adastra Announces Options Grant

LANGLEY, BC / ACCESSWIRE / August 11, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce a grant of incentive options.

Aug 05, 2020 03:00 am ET

Adastra Submits Sales Licence Amendment

LANGLEY, BC / ACCESSWIRE / August 5, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the submission of its federal sales licence amendment to Health Canada.

Jul 31, 2020 03:00 am ET

Adastra Announces Muskoka Grown Split Tolling Agreement

LANGLEY, BC / ACCESSWIRE / July 31, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce a tolling agreement with Muskoka Grown Ltd. ("Muskoka Grown").

Jul 15, 2020 08:40 am ET

Adastra Announces Phyto Extractions Vape Cartridge Order

LANGLEY, BC / ACCESSWIRE / July 15, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the receipt of a purchase order for 30,000 vaporizing cartridges from CannMart Inc. ("CannMart") a majority owned subsidiary of Namaste Technologies Inc. ("Namaste") (N) (M5BQ) (NXTTF) for its Phyto Extractions ("Phyto") licensed brand.

Jul 14, 2020 07:30 am ET

Adastra Closes $3.49 Million Oversubscribed Private Placement

LANGLEY, BC / ACCESSWIRE / July 14, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra", "XTRX", or the "Company") is pleased to announce the closing of its previously announced non-brokered private placement offering (see press releases dated June 18, 2020 and June 25, 2020) issuing 11,648,001 units (the "Units") for aggregate gross proceeds of $3,494,400.

Jun 29, 2020 09:45 pm ET

Adastra Provides Update On Annual and Interim Financial Statements

LANGLEY, BC / ACCESSWIRE / June 29, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX) (FRANKFURT:D2EP) ("Adastra", "XTRX", or the "Company") announces pursuant to the blanket relief granted by the Canadian Securities Administrators, Adastra is providing an update to its press release dated May 30, 2020 announcing that it will not file its interim financial statements for the period ended March 31, 2020, and the related management's discussion and analysis, as required by parts 4 and 5 of National Instrument 51- 102 -- Continuous Disclosure Obli

Jun 25, 2020 03:50 pm ET

Adastra Increases Private Placement Financing

LANGLEY, BC / ACCESSWIRE / June 25, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra", "XTRX", or the "Company") a Health Canada Licensed cannabis processing and analytical testing services company announces that it plans to increase its previously announced private placement offering (see press release dated June 18, 2020), of units (the "Units") at a price of $0.30 per Unit to up to $2,000,000 (the "Offering"), subject to the acceptance of over-allotments as described below.

Jun 18, 2020 07:00 pm ET

Adastra Announces Private Placement Financing

LANGLEY, BC / ACCESSWIRE / June 18, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX) (FRA:D2EP) ("Adastra", "XTRX", or the "Company") a Health Canada Licensed cannabis processing and analytical testing company announced today that it will be conducting a non-brokered private placement of units (the "Units") at a price of $0.30 per Unit for gross proceeds of up to $1,000,000 (the "Offering"), subject to the acceptance of over-allotments as described below.

May 30, 2020 02:00 am ET

Adastra Provides Update on Annual and Interim Financial Statements

LANGELY BC / ACCESSWIRE / May 30, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra"), a Health Canada Licensed cannabis processing and analytical testing services Company, announces, further to its April 24, 2020 news release in relation to the timing of the filing of its year-end financial statements, the corporation now expects to file such documents on or prior to June 12, 2020.

May 22, 2020 07:00 am ET

Adastra Announces Initial Distillate Purchase Order from CannMart

LANGLEY, BC / ACCESSWIRE / May 22, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the receipt of its initial purchase order for bulk distillate from CannMart Inc. ("CannMart") a majority owned subsidiary of Namaste Technologies Inc. ("Namaste") (N) (M5BQ) (NXTTF).

Apr 29, 2020 07:00 am ET

Adastra Labs Announces Appointment of Director of Production

LANGLEY, BC / ACCESSWIRE / April 29, 2020 - Adastra Labs Holdings Ltd. (CSE: XTRX)(FRANKFURT: D2EP) ("Adastra" or the "Company") announces the appointment of Kyle J. Boniface as Director of Production. Dr. Boniface joins Adastra with recent publicly traded cannabis company experience as Director of Product Development and Innovation where he was responsible for cannabis extraction, product development and R&D. Dr. Boniface developed and launched a variety of cannabis products across various formats including sprays, oils, softgels, vaporizing

Apr 24, 2020 07:00 pm ET

Adastra Labs Announces Reliance Upon Annual Financial Statement Filing Exemption

LANGLEY, BC / ACCESSWIRE / April 24, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra" or the "Company") as a result of the COVID-19 pandemic, will be relying on the coordinated relief provided by the securities regulators, which consists of a 45-day extension for certain periodic filings, as announced by the Canadian Securities Administrators (CSA) on March 18, 2020, with respect to the filing of its annual financial statements, management's discussion and analysis, and related officer certificates for its financial year ended

Apr 23, 2020 07:00 am ET

Adastra Announces Completion of Commissioning and Commencement of Operations

LANGLEY, BC / ACCESSWIRE / April 23, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a provider of same-site Health Canada Licensed cannabis processing and analytical testing services, is pleased to announce the completion of Commissioning and Commencement of Operations

Apr 01, 2020 05:00 am ET

Adastra Provides COVID-19 Operational Update and Announces Supply Agreement with Namaste

LANGLEY, BC / ACCESSWIRE / April 1, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a provider of same-site Health Canada Licensed cannabis processing and analytical testing services, is pleased to provide an update with respect to the impact of the COVID-19 pandemic on its current operations and announce the entry into an agreement to supply cannabis extract and concentrate products.

Mar 16, 2020 05:00 am ET

Adastra Labs Receives Health Canada Cannabis Processing Licence

LANGLEY, BC / ACCESSWIRE / March 16, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX) ("the Company") a provider of same site cannabis extraction and analytical testing services, is pleased to announce it's subsidiary Adastra Labs Inc. ("Adastra") has been issued a Standard Processing licence under the Cannabis Regulations by Health Canada. The Standard Processing Licence received by Adastra will be valid for three years and authorizes Adastra to conduct cannabis processing activities at the Company's newly renovated GMP compliant 13,000 sq ft facility loc

Feb 11, 2020 08:30 am ET

Adastra Enters Toll Processing Agreement with Sugarbud

LANGLEY, BC / ACCESSWIRE / February 11, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX) ("Adastra") is pleased to announce that it has entered into an agreement with Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT) ("Sugarbud") to supply cannabis contract (toll) processing services.

Feb 11, 2020 07:00 am ET

Sugarbud Announces Toll Processing Agreement with Adastra Labs and Provides Operational and Corporate Updates

Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT) ("Sugarbud") is pleased to announce that it has entered into a toll processing agreement with Adastra Labs Holdings Ltd. (CSE: XTRX) ("Adastra"). Under the terms of the agreement, Adastra will...

Jan 31, 2020 05:00 pm ET

Adastra Announces Option Grant

LANGLEY, BC / ACCESSWIRE / January 31, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX) ("Adastra") is pleased to announce that as part of the corporation's long term incentive program, and pursuant to the terms and conditions of its stock option plan, the Adastra Board of Directors has approved the grant of 7,570,000 stock options to certain directors, officers, employees and consultants. The options expire five years from the date of grant, vest automatically upon grant, and are exercisable at a price of $0.45 per common share.

Jan 31, 2020 04:24 pm ET

Adastra Labs Announces the Installation of its Cannabis Processing Equipment

LANGLEY, BC / ACCESSWIRE / January 31, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX) ("Adastra") announces the installation of its cannabis processing equipment at their facility Langley, BC (the "Facility"). In early December Adastra accepted the delivery of a GMP-compliant Series 140 supercritical CO2 extraction system and post-processing equipment from extraktLAB, a brand of United Science LLC. The installation of the equipment required the sanitary supply of liquid CO2, CO2 exhaust, compressed air, chiller lines an

Jan 06, 2020 07:00 am ET

Adastra Labs Holdings Ltd. Commences Trading on CSE

VANCOUVER, B.C. / ACCESSWIRE / January 6, 2020 / Adastra Labs Holdings Ltd. (formerly Arrowstar Resources Ltd. ("Adastra" or the "Company") is pleased to announce the Canadian Securities Exchange (the "CSE") has approved the listing of its shares on the CSE. Effective January 6, 2020 the shares will commence trading under the symbol XTRX.

Ad blocking detected

Adastra Holdings Ltd. (C:XTRX)

Business Focus: Alternative Medicine